Skip to main content

Advertisement

Fig. 2 | Clinical Epigenetics

Fig. 2

From: Associations and prognostic implications of Eastern Cooperative Oncology Group performance status and tumoral LINE-1 methylation status in stage III colon cancer patients

Fig. 2

Survival analyses. a Low LINE-1 methylation status was closely associated with shorter RFS times (P = 0.049). b There was no significant difference in recurrence-free survival according to the performance status (PS) score. c Survival analysis in patients with overweight BMI score according to the tumor to normal ratio (TNR) of LINE-1 methylation level. d In survival analysis stratified by combinatory PS and LINE-1 methylation statuses, recurrence-free survival was significantly different between PS(0)/LINE-1(high) and PS(1)/LINE-1(low) (P = 0.037)

Back to article page